50 filings
8-K
TLSI
TriSalus Life Sciences Inc
30 Apr 24
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNavĀ® Infusion System Growth Initiatives
5:00pm
8-K
TLSI
TriSalus Life Sciences Inc
15 Apr 24
Changes in Registrant's Certifying Accountant
5:43pm
8-K
TLSI
TriSalus Life Sciences Inc
1 Apr 24
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
8:05am
8-K
TLSI
TriSalus Life Sciences Inc
11 Mar 24
Results of Operations and Financial Condition
9:25pm
8-K
TLSI
TriSalus Life Sciences Inc
25 Jan 24
Departure of Directors or Certain Officers
5:19pm
8-K
xpgv8 y2o
5 Jan 24
Results of Operations and Financial Condition
4:28pm
8-K
qdiv0
14 Nov 23
TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
aequxcu815r x103d
3 Oct 23
Standby Equity Purchase Agreement
6:01am
8-K
ixnsl64f
1 Sep 23
Regulation FD Disclosure
4:01pm
8-K
3rolm
16 Aug 23
Entry into a Material Definitive Agreement
4:37pm
8-K
98qh8s
9 Aug 23
Submission of Matters to a Vote of Security Holders
7:05am
8-K
6xbm di6i
2 Aug 23
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders
5:05pm
8-K
0cvtuxo2 o0voz7z
2 Aug 23
Other Events
7:05am
8-K
ybiehc0raczp1hi 5p2
21 Jul 23
Other Events
7:00am
8-K
hcnu84pfa 0n71ap
6 Jul 23
Entry into a Material Definitive Agreement
7:00am
8-K
ofi0ibn xntn8
30 Jun 23
Unregistered Sales of Equity Securities
4:10pm
8-K
yzsu e1of7tnm1i2
21 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
5sqkmxwqgys8
15 Jun 23
Entry into a Material Definitive Agreement
4:10pm
8-K
vkurpmvoxxm9 wk
12 Jun 23
Regulation FD Disclosure
7:05am
8-K
3fy 3c1iq8bb
8 Jun 23
Entry into a Material Definitive Agreement
7:00am